Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme
Open Access
- 16 May 2013
- journal article
- Published by Springer Nature in BMC Dermatology
- Vol. 13 (1) , 1-7
Abstract
Background: Parents and carers of children with eczema often underuse emollient therapy, essential to repairing and protecting the defective skin barrier in atopic eczema. Educational interventions delivered by specialist dermatology nurses in hospital settings have been shown to improve emollient use and reduce symptoms of atopic eczema, but benefits of community-based interventions are uncertain. Support and information about appropriate care may often be inadequate for patients and carers in the community.Methods: A multifaceted educational support programme was evaluated as a method of increasing emollient use and reducing atopic eczema in children. Support provided for parents and carers included an educational DVD, online daily diary and telephone helpline. The before and after study included 136 British children and their parents, providing baseline and 12 week follow-up data while receiving the programme. Measures included emollient use, POEM and PEST scores, and cost of care.Results: Average emollient use increased by 87.6 g (95% CI: 81.9 to 119.5 g, p = 0.001) from baseline with the change being immediate and persistent. The POEM score reduced on average by 5.38 (95% CI: 4.36 to 6.41, p = 0.001), a 47% reduction from baseline. Similarly the PEST score reduced on average by 0.61 (95% CI: 0.47 to 0.75, p = 0.001), a 48% reduction from baseline. Sleep disturbance was reduced by 1.27 nights per week (95% CI: 0.85 to 1.68, p = 0.001) and parental feeling of control improved by 1.32 points (95% CI: 1.16 to 1.48, p = 0.001). From the NHS perspective, the programme was cost neutral overall within the study period.Conclusion: A community-based multifaceted educational support programme greatly increased emollient use, reducing symptoms of atopic eczema and general practitioner contacts, without increasing cost. Significant benefits may accrue to the families and carers of children with atopic eczema due to improved sleep patterns and greater feeling of control. PEST, a new simple measure of acute and remitting atopic eczema severity designed to help parents and children to monitor and manage eczema, merits further evaluation.Keywords
This publication has 21 references indexed in Scilit:
- E‐health in caring for patients with atopic dermatitis: a randomized controlled cost‐effectiveness study of internet‐guided monitoring and online self‐management trainingBritish Journal of Dermatology, 2012
- Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasisBritish Journal of Dermatology, 2011
- Questionnaire survey of the efficacy of emollients for adult patients with atopic dermatitisThe Journal of Dermatology, 2010
- Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthmaCochrane Database of Systematic Reviews, 2009
- Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trialBMJ, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- The Patient-Oriented Eczema MeasureArchives of Dermatology, 2004
- Specialist outreach clinics in primary care and rural hospital settings.Cochrane Database of Systematic Reviews, 2003
- The importance of skin barrier functionJournal of Dermatological Treatment, 1997
- What do members of the National Eczema Society really want?Clinical and Experimental Dermatology, 1993